The life sciences business developing compounds to tackle obesity, high cholesterol and diabetes today provided a research update on its research and development programmes.
17 Apr 2015
Research on track, suggesting broader range of applications
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Research on track, suggesting broader range of applications
OptiBiotix Health PLC (OPTI:LON) | 18.0 0 0.0% | Mkt Cap: 17.6m
- Published:
17 Apr 2015 -
Author:
Derren Nathan -
Pages:
3
The life sciences business developing compounds to tackle obesity, high cholesterol and diabetes today provided a research update on its research and development programmes.